Cargando…

Correction to: Usefulness of Fibrosis-4 (FIB-4) score and metabolic alterations in the prediction of SARS-CoV-2 severity

Detalles Bibliográficos
Autores principales:	Lombardi, Rosa, La Mura, Vincenzo, Cespiati, Annalisa, Iuculano, Federica, Sigon, Giordano, Pallini, Giada, Proietti, Marco, Motta, Irene, Montinaro, Beatrice, Fiorelli, Elisa, Cesari, Matteo, Bandera, Alessandra, Valenti, Luca, Peyvandi, Flora, Montano, Nicola, Baldini, Marina, Fracanzani, Anna Ludovica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302863/ https://www.ncbi.nlm.nih.gov/pubmed/35864374 http://dx.doi.org/10.1007/s11739-022-03056-z

Ejemplares similares

Usefulness of fibrosis-4 (FIB-4) score and metabolic alterations in the prediction of SARS-CoV-2 severity
por: Lombardi, Rosa, et al.
Publicado: (2022)

Nutrients, Genetic Factors, and Their Interaction in Non-Alcoholic Fatty Liver Disease and Cardiovascular Disease
por: Lombardi, Rosa, et al.
Publicado: (2020)

Hypercoagulability in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD): Causes and Consequences
por: Tripodi, Armando, et al.
Publicado: (2022)

Impact of Sarcopenia and Myosteatosis in Non-Cirrhotic Stages of Liver Diseases: Similarities and Differences across Aetiologies and Possible Therapeutic Strategies
por: Cespiati, Annalisa, et al.
Publicado: (2022)

An Overview of Hepatocellular Carcinoma Surveillance Focusing on Non-Cirrhotic NAFLD Patients: A Challenge for Physicians
por: Cespiati, Annalisa, et al.
Publicado: (2023)

Interaction between Lifestyle Changes and PNPLA3 Genotype in NAFLD Patients during the COVID-19 Lockdown
por: Cinque, Felice, et al.
Publicado: (2022)

The I148M PNPLA3 variant mitigates niacin beneficial effects: How the genetic screening in non-alcoholic fatty liver disease patients gains value
por: Paolini, Erika, et al.
Publicado: (2023)

Impact of deterioration of lifestyle and PNPLA3 genotype in NALFD patients during COVID-19 lockdown
por: Cinque, F., et al.
Publicado: (2022)

Comparison between the first and second COVID-19 waves in Internal Medicine wards in Milan, Italy: a retrospective observational study
por: Blanca, Deborah, et al.
Publicado: (2022)

COVID-19 Network: the response of an Italian Reference Institute to research challenges about a new pandemia
por: Bandera, A., et al.
Publicado: (2020)

Anakinra combined with methylprednisolone in patients with severe COVID-19 pneumonia and hyperinflammation: An observational cohort study
por: Bozzi, Giorgio, et al.
Publicado: (2021)

IncFIB-4.1 and IncFIB-4.2 Single-Replicon Plasmids: Small Backbones with Large Accessory Regions
por: Xu, Yanan, et al.
Publicado: (2022)

Residual burden of liver disease after HCV clearance in hemophilia: a word of caution in the era of gene therapy
por: La Mura, Vincenzo, et al.
Publicado: (2023)

FIB-5 versus FIB-4 index for assessment of hepatic fibrosis in chronic hepatitis B affected patients
por: Metwally, Khaled, et al.
Publicado: (2020)

Utility of FIB4-T as a Prognostic Factor for Hepatocellular Carcinoma
por: Kariyama, Kazuya, et al.
Publicado: (2019)

Glomerular Hyperfiltration: A Marker of Fibrosis Severity in Metabolic Associated Steatotic Liver Disease in an Adult Population
por: Dalbeni, Andrea, et al.
Publicado: (2023)

Nutritional and Lifestyle Therapy for NAFLD in People with HIV
por: Cinque, Felice, et al.
Publicado: (2023)

FIB nanostructures
por: Wang, Zhiming M
Publicado: (2013)

Remdesivir-induced bradycardia in patients hospitalized with SARS-CoV2 infection: a possible vagally-mediated mechanism
por: Filtz, Annalisa, et al.
Publicado: (2022)

Liver Fibrosis Index FIB‐4 Is Associated With Mortality in COVID‐19
por: Li, Yijia, et al.
Publicado: (2020)

Assessing Liver Fibrosis Using the FIB4 Index in the Community Setting
por: Blanco-Grau, Albert, et al.
Publicado: (2021)

Role of FIB-4 for reassessment of hepatic fibrosis burden in referral center
por: Roh, Yun Hwa, et al.
Publicado: (2021)

Diagnostic Accuracy of FIB-4 and FIB-5 Scores as Compared to Fibroscan for Assessment of Liver Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease
por: Kumari, Bandana, et al.
Publicado: (2021)

Comparing Xe(+)pFIB and Ga(+)FIB for TEM sample preparation of Al alloys: Minimising FIB‐induced artefacts
por: Zhong, Xiangli, et al.
Publicado: (2020)

Fibrosis-4 (FIB-4) Index and mortality in COVID-19 patients admitted to the emergency department
por: Bucci, Tommaso, et al.
Publicado: (2022)

Vascular Damage in Patients with Nonalcoholic Fatty Liver Disease: Possible Role of Iron and Ferritin
por: Pisano, Giuseppina, et al.
Publicado: (2016)

APRI and FIB-4 scores are not associated with neurocognitive impairment in HIV-infected persons
por: Libertone, Raffaella, et al.
Publicado: (2014)

FIB the fractured femur
por: Shahzad, H, et al.
Publicado: (2013)

On-Treatment Changes in FIB-4 and 1-Year FIB-4 Values Help Identify Patients with Chronic Hepatitis B Receiving Entecavir Therapy Who Have the Lowest Risk of Hepatocellular Carcinoma
por: Wang, Hung-Wei, et al.
Publicado: (2020)

FibH Gene Complete Sequences (FibHome) Revealed Silkworm Pedigree
por: Lu, Wei, et al.
Publicado: (2023)

Fib-4 score is able to predict intra-hospital mortality in 4 different SARS-COV2 waves
por: Miele, Luca, et al.
Publicado: (2023)

Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population
por: Sumida, Yoshio, et al.
Publicado: (2012)

An Elevated FIB-4 Score Is Associated with an Increased Incidence of Depression among Outpatients in Germany
por: Schöler, David, et al.
Publicado: (2022)

Non-Invasive Detection of Fibrotic NASH in NAFLD Patients with Low or Intermediate FIB-4
por: John, Katharina, et al.
Publicado: (2022)

Repurposing FIB-4 index as a predictor of mortality in patients with hematological malignancies and COVID-19
por: Sutandyo, Noorwati, et al.
Publicado: (2021)

A higher FIB‐4 index is associated with an increased incidence of renal failure in the general population
por: Schleicher, Eva Maria, et al.
Publicado: (2022)

FIB-4 Index and Neutrophil-to-Lymphocyte-Ratio as Death Predictor in Coronary Artery Disease Patients
por: Gaggini, Melania, et al.
Publicado: (2022)

FRI429 Association Between Nonalcoholic Fatty Liver Disease And Fib-4 In Patients With Hypogonadism
por: Godar, Cassandra M, et al.
Publicado: (2023)

Fibrosis-4 (FIB-4) index as a predictor for mechanical ventilation and 30-day mortality across COVID-19 variants
por: Parajuli, Priyanka, et al.
Publicado: (2023)

Romeo and Juliet: Revisited (at the time of COVID-19)
por: Costantino, Giorgio, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4js5jpg2v9k835fka6r0mftc1m